The apelin receptor APJ: journey from an orphan to a multifaceted regulator of homeostasis

  1. George R Pope
  1. Henry Wellcome Laboratories for Integrative Neuroscience and Endocrinology, School of Clinical Sciences, University of Bristol, Dorothy Hodgkin Building, Whitson Street, Bristol BS1 3NY, UK
  1. Correspondence should be addressed to A-M O'Carroll; Email: A.M.OCarroll{at}bristol.ac.uk
  1. Figure 1

    Amino acid sequence of mature rat apelin isoforms. Amino acid sequences of (A) (Pyr1)apelin-13, (B) apelin-13, (C) apelin-17 and (D) apelin-36. Black circled residues indicate those identical between human, bovine, rat and mouse.

  2. Figure 2

    Apelin and APJ gene expression in rat tissues. Gene expression of apelin/APJ in the rat (see text for details). There have been fewer studies demonstrating the expression of apelin and/or APJ protein in the rat (or other species including humans) or determining whether apelin and APJ are localised in different cell populations or co-expressed within a given tissue. Examples of rat tissues where both apelin and/or APJ gene and immunoreactive protein/binding sites have been found (and may be functionally relevant) include the brain, pituitary, lung, heart, gastrointestinal tract, liver and kidney (see text and references Hus-Citharel et al. (2008), Wang et al. (2009), Zeng et al. (2009) and Piairo et al. (2011) for details).

  3. Figure 3

    Overview of APJ signalling pathways. Schematic diagram of APJ signalling pathways. Coupling to Gq/11 stimulates PLC-β signalling, including the hydrolysis of phosphatidylinositol 4,5-biphosphate (PIP2) to IP3 and diacyl glycerol (DAG). DAG subsequently activates PKC, which is an activator of the small G-protein, Ras. Ras then either activates a cascade leading to the activation of JNK, and the transcription factors SP1 and c-Jun or the MAPK cascade of Raf-1, MAPK-/ERK kinase (MEK1/2) and ERK1/2. ERK1/2 have a variety of substrates including numerous transcription factors (e.g. c-Jun and c-fos) and other kinases (e.g. p70S6K). Gq/11 also signals independently of PKC, but still via Ras and the MAPK cascade. Gi/o stimulates the MAPK cascade via PKC, and it can also activate phosphoinositide 3-kinase (PI3K) with the subsequent activation of Akt and mammalian target of rapamycin (mTOR), leading to the activation of both p70S6K and endothelial nitric oxide synthase (eNOS). Furthermore, Gi/o signalling inhibits adenylate cyclase (AC) activity. In contrast, Gs activates AC, increasing cAMP synthesis from ATP, leading to the activation of protein kinase A (PKA). Thin black arrows indicate activation pathways and the red blunted arrow indicates inhibition.

| Table of Contents